Cargando…

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension

Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Jina, Shin, Nami, Ahn, Kyung-Jin, Seo, Miryoung, Jang, Albert Youngwoo, Kim, Minsu, Chung, Wook-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/
https://www.ncbi.nlm.nih.gov/pubmed/35361265
http://dx.doi.org/10.1186/s40885-021-00191-1
_version_ 1784680163820175360
author Yeo, Jina
Shin, Nami
Ahn, Kyung-Jin
Seo, Miryoung
Jang, Albert Youngwoo
Kim, Minsu
Chung, Wook-Jin
author_facet Yeo, Jina
Shin, Nami
Ahn, Kyung-Jin
Seo, Miryoung
Jang, Albert Youngwoo
Kim, Minsu
Chung, Wook-Jin
author_sort Yeo, Jina
collection PubMed
description Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of this condition. Herein, we reviewed the case of a 56-year-old female who was diagnosed with PAH related to APS that mimicked chronic thromboembolic pulmonary hypertension (CTEPH). It is crucial to be aware of the possibility of a group 1 PAH diagnosis, even though patients have already been diagnosed with CTEPH. Furthermore, a multidisciplinary approach and serial follow-up right heart catheterization with echocardiography are important to make a timely diagnosis and provide optimal treatment for APS-related PAH in patients with CTEPH-like clinical features.
format Online
Article
Text
id pubmed-8973988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89739882022-04-02 Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension Yeo, Jina Shin, Nami Ahn, Kyung-Jin Seo, Miryoung Jang, Albert Youngwoo Kim, Minsu Chung, Wook-Jin Clin Hypertens Letter to the Editor Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of this condition. Herein, we reviewed the case of a 56-year-old female who was diagnosed with PAH related to APS that mimicked chronic thromboembolic pulmonary hypertension (CTEPH). It is crucial to be aware of the possibility of a group 1 PAH diagnosis, even though patients have already been diagnosed with CTEPH. Furthermore, a multidisciplinary approach and serial follow-up right heart catheterization with echocardiography are important to make a timely diagnosis and provide optimal treatment for APS-related PAH in patients with CTEPH-like clinical features. BioMed Central 2022-04-01 /pmc/articles/PMC8973988/ /pubmed/35361265 http://dx.doi.org/10.1186/s40885-021-00191-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Yeo, Jina
Shin, Nami
Ahn, Kyung-Jin
Seo, Miryoung
Jang, Albert Youngwoo
Kim, Minsu
Chung, Wook-Jin
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title_full Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title_fullStr Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title_full_unstemmed Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title_short Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
title_sort pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/
https://www.ncbi.nlm.nih.gov/pubmed/35361265
http://dx.doi.org/10.1186/s40885-021-00191-1
work_keys_str_mv AT yeojina pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT shinnami pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT ahnkyungjin pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT seomiryoung pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT jangalbertyoungwoo pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT kimminsu pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension
AT chungwookjin pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension